Nxera Pharma Receives US$10 Million From Abbvie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
Nxera Pharma因與艾伯維公司合作在神經系統疾病研究領域取得首個研發里程碑而獲得1000萬美元資金。
Nxera Pharma Receives US$10 Million From Abbvie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
Nxera Pharma因與艾伯維公司合作在神經系統疾病研究領域取得首個研發里程碑而獲得1000萬美元資金。
譯文內容由第三人軟體翻譯。